Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole

Published:2008-01-14 Issue:24 Volume:27 Page:3435-3445
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Goda A E,Yoshida T,Horinaka M,Yasuda T,Shiraishi T,Wakada M,Sakai T

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1211008.pdf

Reference35 articles.

1. Altieri DC . (2003). Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3: 46–54.

2. Aouad SM, Cohen LY, Sharif-Askari E, Haddad EK, Alam A, Sekaly RP . (2004). Caspase-3 is a component of Fas death-inducing signaling complex in lipid rafts and its activity is required for complete caspase-8 activation during Fas-mediated cell death. J Immunol 172: 2316–2323.

3. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA et al. (1999). Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104: 155–162.

4. Azuhata T, Scott D, Griffith TS, Miller M, Sandler AD . (2006). Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma. J Pediatr Surg 41: 1431–1440.

5. Carlo-Stella C, Lavazza C, Locatelli A, Vigano L, Gianni AM, Gianni L . (2007). Targeting TRAIL agonistic receptors for cancer therapy. Clin Cancer Res 13: 2313–2317.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dipyridamole interacts with the N-terminal domain of HSP90 and antagonizes the function of the chaperone in multiple cancer cell lines;Biochemical Pharmacology;2023-01

2. Star-Shaped Polylactide Dipyridamole Conjugated to 5-Fluorouracil and 4-Piperidinopiperidine Nanocarriers for Bioimaging and Dual Drug Delivery in Cancer Cells;ACS Applied Polymer Materials;2021-01-04

3. Enhanced anticancer activity of combined treatment of imatinib and dipyridamole in solid Ehrlich carcinoma-bearing mice;Naunyn-Schmiedeberg's Archives of Pharmacology;2020-01-16

4. Dipyridamole Enhances the Cytotoxicities of Trametinib against Colon Cancer Cells through Combined Targeting of HMGCS1 and MEK Pathway;Molecular Cancer Therapeutics;2019-09-25

5. Targeting the death receptor signaling pathway as a potential therapeutic target in the treatment of colorectal cancer;Journal of Cellular Physiology;2018-05-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3